Drug Type Enzyme |
Synonyms Lanoteplase (genetical recombination) (JAN), Lanoteplase (USAN/INN), nPA + [6] |
Target |
Action stimulants |
Mechanism PLG stimulants(Plasminogen stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myocardial Infarction | NDA/BLA | Japan | - | - |
Myocardial Ischemia | Phase 3 | United States | - | - |
Myocardial Ischemia | Phase 3 | - | - | |
Myocardial Ischemia | Phase 3 | - | - | |
Myocardial Ischemia | Phase 3 | - | - | |
Thrombosis | Phase 3 | United States | - | - |
Thrombosis | Phase 3 | - | - | |
Thrombosis | Phase 3 | - | - | |
Thrombosis | Phase 3 | - | - |